No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
HK Stock MarketDetailed Quotes
02257 SIRNAOMICS-B
- 3.410
- -0.190-5.28%
Market Closed Dec 20 16:08 CST
358.62MMarket Cap-0.56P/E (TTM)
3.570High3.320Low145.25KVolume3.430Open3.600Pre Close509.57KTurnover0.14%Turnover RatioLossP/E (Static)105.17MShares41.00052wk High189.44P/B358.62MFloat Cap2.35052wk Low--Dividend TTM105.17MShs Float101.000Historical High--Dividend LFY6.94%Amplitude2.350Historical Low3.508Avg Price50Lot Size--Div YieldTTM--Div Yield LFY
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | The USA Biological Security Act was not included in the CR bill.
The Concept of Innovative Drugs mostly rose, with Shengnuo Pharmaceutical (02257) increasing by 11.56%. Institutions indicate that pharmaceutical innovation is the core driving force of pharmaceutical growth.
Jinwu Finance | Most Innovative Drug Concepts have risen, with Saint Nutra Pharma (02257) up 11.56%, Baiao Saitu (02315) up 9.68%, Geli Pharma (01672) up 7.98%, Lvzhu Bio (02480) up 4.73%, ZAI LAB (09688) up 4.41%, Connaught (02162) up 1.34%, SINO BIOPHARM (01177) up 0.95%, INNOVENT BIO (01801) up 0.69%. Galaxy Securities stated that 1) pharmaceutical innovation is the core driving force of pharmaceutical growth. Innovative drugs have transitioned from Me-too to
Saint No Pharmaceutical (02257.HK) changes auditor.
Saint Nor Medical-B (02257.HK) announced that it received a resignation letter from Deloitte & Touche dated last Friday (the 13th). In addition, Zhonghui Anda Certified Public Accountants has been appointed as the company's auditor, also effective from last Friday, to fill the temporary vacancy left by Deloitte's resignation, and will serve until the end of the company's next annual general meeting of Shareholders.
The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!
Industry pessimistic expectations may improve.
How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.
① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.
Sinoun Pharmaceutical-B (02257): Wong Man Chung resigns as a non-executive director.
Sanofi Pharmaceutical - B (02257) announced that the board of directors received Mr. Wong Man Chung's resignation letter, as Mr. Wong Man Chung intends to pursue other opportunities...
Trending HK Stocks
HK Dividend Stocks HK Dividend Stocks
Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data. Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data.
